Immunotherapy in recurrent/metastatic head and neck squamous cell carcinoma: PD-L1 and beyond
{{output}}
Head and neck squamous cell carcinoma (HNSCC) is a prominent global health concern because of its high incidence, aggressive clinical behavior, and scarce therapeutic options. The management of these neoplasms in the recurrent/metastatic setting has been revol... ...